5-methyl-6,7-dihydro-4H-thieno[3,2-c]pyridine-2-carbonitrile

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩并吡啶类
• 英文名称: 5-methyl-6,7-dihydro-4H-thieno[3,2-c]pyridine-2-carbonitrile
• 化学式: C₉H₁₀N₂S
• 分子量: 178.26
• InChiKey: KOMDBTMKOCTDIZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  55.3
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• [EN] FUSED HETEROCYCLYL DERIVATIVES AS NAMPT INHIBITORS<br/>[FR] DÉRIVÉS HÉTÉROCYCLYLES FUSIONNÉS EN TANT QU'INHIBITEURS NAMPT
  申请人：AURIGENE DISCOVERY TECH LTD

  公开号：WO2014141035A2

  公开（公告）日：2014-09-18

  The present invention provides substituted heterocyclyl derivatives of formula (I), which may be therapeutically useful, more particularly as NAMPT inhibitors; in which R1, R2, X1, X2, ring A, L and 'n' have the meanings given in the specification, and pharmaceutically acceptable salts thereof that are useful in the treatment and prevention of diseases or disorder caused by an elevated level of nicotinamide phosphoribosyltransferase (NAMPT) in a mammal. The present invention also provides preparation of the compounds and pharmaceutical formulations comprising at least one of the substituted fused heterocyclyl derivatives of formula (I) or pharmaceutically acceptable salts or stereoisomers thereof.